P864: A PHASE 1 STUDY OF BELANTAMAB MAFODOTIN IN COMBINATION WITH STANDARD OF CARE IN NEWLY DIAGNOSED MULTIPLE MYELOMA: AN INTERIM ANALYSIS OF DREAMM-9

• Saad Z Usmani,
• Michał Mielnik,
• Ja Min Byun,
• Aránzazu Alonso Alonso,
• Al-Ola Abdallah,
• Mamta Garg,
• Hang Quach,
• Chang-Ki Min,
• Wojciech Janowski,
• Enrique Maria Ocio San Miguel,
• Katja Weisel,
• Albert Oriol,
• Irwindeep Sandhu,
• Paula Rodríguez-Otero,
• Karthik Ramasamy,
• Jacqueline Egger,
• Danaè Williams,
• Jie MA,
• Morrys Kaisermann,
• Marek Hus

Affiliations

Saad Z Usmani

1 Memorial Sloan Kettering Cancer Center, New York City, United States

Michał Mielnik

2 Medical University of Lublin, Lublin, Poland

Ja Min Byun

3 Seoul National University Hospital, Seoul, Korea, Rep. of South

Aránzazu Alonso Alonso

4 Hospital Quirón Madrid, Madrid, Spain

Al-Ola Abdallah

5 University of Kansas Medical Center, US Myeloma Research Innovations Research Collaborative (USMIRC), Westwood, United States

Mamta Garg

6 Leicester Royal Infirmary, Leicester, United Kingdom

Hang Quach

7 St Vincent’s Hospital Melbourne, University of Melbourne, Melbourne, Australia

Chang-Ki Min

8 The Catholic University of Korea Seoul St. Mary’s Hospital, Seoul, Korea, Rep. of South

Wojciech Janowski

9 Calvary Mater Newcastle, Newcastle, Australia

Enrique Maria Ocio San Miguel

10 Hospital Universitario Marqués de Valdecilla (IDIVAL), Universidad de Cantabria, Santander, Spain

Katja Weisel

11 University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Albert Oriol

12 Institut Català d’Oncologia and Institut Josep Carreras - Hospital Universitari Germans Trias i Pujol (HUGTP), Badalona, Spain

Irwindeep Sandhu

13 University of Alberta, Alberta, Canada

Paula Rodríguez-Otero

14 Department of Hematology, Clínica Universidad de Navarra, Pamplona, Spain

Karthik Ramasamy

15 Churchill Hospital, Oxford, United Kingdom

Jacqueline Egger

16 GSK, Herfordshire, United Kingdom

Danaè Williams

17 GSK, Upper Providence, United States

Jie MA

18 GSK, Waltham, United States

Morrys Kaisermann

17 GSK, Upper Providence, United States

Marek Hus

2 Medical University of Lublin, Lublin, Poland